MASURATION Awarded Cluster Life Sciences Award

MASURATION Awarded Cluster Life Sciences Award by Standortagentur Tirol. Innsbruck, Austria – March 13, 2024.

MASURATION, a leading provider of a unique innovative surgical navigation technology, has been honored with the Life Sciences Award. The award recognizes MASURATION’s significant contributions to the medical technology industry worldwide. The award was presented to MASURATION Co-founders Dr. Yusuf Özbek and Prof. Wolfgang Freysinger at a ceremony held on March 12, 2024, in Innsbruck.

Dr. Yusuf Özbek expressed his gratitude for the recognition and emphasized MASURATION’s commitment to advancing life sciences research and development of an innovative product named “Noctopus” in Tirol. “We are proud to receive this prestigious award, which acknowledges the hard work and dedication,” said Dr. Özbek. MASURATION is dedicated to the advancement of cutting-edge technologies that usher in a new era in surgical navigation field and enhance patient safety during various surgical procedures, including neurosurgery, ENT, spine, orthopedics, biopsy, interventional radiology, and numerous other surgical specialties.

MASURATION’s patented Noctopus platform has the potential to supplant conventional methods employed in computer-assisted surgery, which are currently utilized in the everyday clinical practice for a wide range of surgical procedures. The company’s Noctopus technology enables more efficient and targeted interventions with an unparalleled accuracy, resulting in improved patient outcomes and reduced side effects of inaccurate surgical navigation.

The Cluster Life Sciences Award is presented every two years to companies that have made significant contributions to the life sciences industry in Tirol. The award recognizes companies that are driving innovation and strengthening the life sciences ecosystem in the region. MASURATION’s receipt of the Cluster Life Sciences Award is a testament to the company’s commitment to advancing life sciences research and development in Tirol. The company’s innovative technology has the potential to improve the lives of patients around the world.